<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HC8C2702BF53A44118C86EC5DDA4D7290" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 5092 IH: Flu Vaccine Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-02-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 5092</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180226">February 26, 2018</action-date><action-desc><sponsor name-id="D000216">Ms. DeLauro</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To conduct or support further comprehensive research for the creation of a universal influenza
			 vaccine.</official-title></form>
	<legis-body id="H99C0C65ACD61471D85377CC5BEB09266" style="OLC">
 <section id="H67751FFBB545416DB6A6395E7260EF02" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Flu Vaccine Act</short-title></quote>.</text> </section><section id="HB151C1A750C742EEB20F62E5FEC552A1"><enum>2.</enum><header>Research for the creation of a universal influenza vaccine</header> <subsection id="H48B9A95502C14C118EBA687682BD0B2B"><enum>(a)</enum><header>In general</header><text>The Director of the National Institute of Allergy and Infectious Diseases shall conduct or support comprehensive research for the creation of a universal influenza vaccine.</text>
 </subsection><subsection id="H566E871FEAAB46DCA3EEB546AFB1F44C"><enum>(b)</enum><header>Authorization of appropriations</header><text>To carry out this section, there are authorized to be appropriated $200,000,000 for each of fiscal years 2019 through 2023.</text>
			</subsection></section></legis-body></bill>


